Terms: = Breast cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
1457 results:
1. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract] [Full Text] [Related]
2. Evolution of neoadjuvant therapy for breast cancer regimens over 12 years and pathologic response rates according to tumor subtypes and clinical stage: A single-center retrospective study.
Li Z; Wang Y
J Cancer Res Ther; 2024 Apr; 20(2):608-614. PubMed ID: 38687931
[TBL] [Abstract] [Full Text] [Related]
3. Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1/JNK pathway.
Shi W; Wang J; Chen J; Jin X; Wang Y; Yang L
J Cancer Res Clin Oncol; 2024 Apr; 150(4):218. PubMed ID: 38678126
[TBL] [Abstract] [Full Text] [Related]
4. Breaking Physical Barrier of Fibrotic breast cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming cancer-Associated Fibroblasts.
Qiu ZW; Zhong YT; Lu ZM; Yan N; Kong RJ; Huang JQ; Li ZF; Nie JM; Li R; Cheng H
ACS Nano; 2024 Apr; 18(13):9713-9735. PubMed ID: 38507590
[TBL] [Abstract] [Full Text] [Related]
5. [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
Li ZM; Liang ZH; Liu N; Wei KR
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):232-238. PubMed ID: 38494769
[No Abstract] [Full Text] [Related]
6. Clinicopathological features and prognostic value of CD276 expression in female reproductive system malignancies: A meta-analysis.
Su H; Hao JJ; Xu YB; Zhang FH
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):154-160. PubMed ID: 38485307
[TBL] [Abstract] [Full Text] [Related]
7. Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer.
Pei J; Peng Y; Ma K; Lan C; Zhang T; Li Y; Chen X; Gao H
BMC Genomics; 2024 Mar; 25(1):250. PubMed ID: 38448802
[TBL] [Abstract] [Full Text] [Related]
8. The crucial role of age and site in incidence and prognosis of female neuroendocrine neoplasms in the United States: a population-based study from 2000 to 2018.
Xiao G; Xu Z; Zhang Y; Dai S; Ouyang G; Huang Y; Liu Y; Cao D; Luo F
Aging (Albany NY); 2024 Mar; 16(5):4204-4223. PubMed ID: 38431305
[TBL] [Abstract] [Full Text] [Related]
9. Epidemiology of breast, Corpus Uteri, and Ovarian cancers in Lebanon With Emphasis on breast cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates.
Lakkis NA; Abdallah RM; Musharrafieh UM; Issa HG; Osman MH
Cancer Control; 2024; 31():10732748241236266. PubMed ID: 38419342
[TBL] [Abstract] [Full Text] [Related]
10. Genistin Represses the Proliferation and Angiogenesis While Accelerating the Apoptosis of Glioma Cells by Modulating the FOXC1-Mediated Wnt Signaling Pathway.
Lan X; Gui Z; Chen T; Tang M; Wang H
Discov Med; 2024 Feb; 36(181):332-342. PubMed ID: 38409838
[TBL] [Abstract] [Full Text] [Related]
11. Comparative Analysis of Mortality due to breast cancer and Mammography Uptake in the Federative Units of Brazil-2015 to 2021.
Dos Santos L; Roszkowski I; Pujals C; de Oliveira RR; Pelloso FC; Pelloso Borghesan DH; Romani I; Romanio Bitencourt M; Jacinto Alarcão AC; Dias Marques V; Pereira Silva MA; Carvalho MDB; Pedroso RB; Pelloso SM
Asian Pac J Cancer Prev; 2023 Jun; 24(12):4339-4348. PubMed ID: 38402419
[TBL] [Abstract] [Full Text] [Related]
12. Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02).
Phillips C; Pinkham MB; Moore A; Sia J; Jeffree RL; Khasraw M; Kam A; Bressel M; Haworth A
Breast; 2024 Apr; 74():103675. PubMed ID: 38340685
[TBL] [Abstract] [Full Text] [Related]
13. Identification of a Panel of miRNAs Associated with Resistance to Palbociclib and Endocrine Therapy.
Torrisi R; Vaira V; Giordano L; Fernandes B; Saltalamacchia G; Palumbo R; Carnaghi C; Basilico V; Gentile F; Masci G; De Sanctis R; Santoro A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338777
[TBL] [Abstract] [Full Text] [Related]
14. Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative breast cancer.
Gardi N; Chaubal R; Parab P; Pachakar S; Kulkarni S; Shet T; Joshi S; Kembhavi Y; Chandrani P; Quist J; Kowtal P; Grigoriadis A; Sarin R; Govindarajan R; Gupta S
Cancer Res Commun; 2024 Feb; 4(2):404-417. PubMed ID: 38315150
[TBL] [Abstract] [Full Text] [Related]
15. Temporal Pattern and Age-Period-Cohort Analysis of breast cancer Incidence in Iranian Women (2009-2017).
Eslahi M; Roshandel G; Khanjani N
Arch Iran Med; 2023 Jun; 26(6):285-289. PubMed ID: 38310428
[TBL] [Abstract] [Full Text] [Related]
16. Disparities in Mortality Trends of breast cancer by Racial and Ethnic Status in the United States.
Doddi S; Hibshman T; Salichs O; Tirumani SH
Anticancer Res; 2024 Feb; 44(2):751-755. PubMed ID: 38307581
[TBL] [Abstract] [Full Text] [Related]
17. Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study.
Didembourg M; Reda S; Oldenburg J; Rühl H; Douxfils J; Morimont L
Int J Lab Hematol; 2024 Jun; 46(3):546-554. PubMed ID: 38296772
[TBL] [Abstract] [Full Text] [Related]
18. Analyzing cancer Incidence Trends in Oman From 1996 to 2019: A Comprehensive Study of the National cancer Annual Reports.
Al-Sayegh H; Al-Zadjali S; Al-Moundhri M
JCO Glob Oncol; 2024 Jan; 10():e2300337. PubMed ID: 38271648
[TBL] [Abstract] [Full Text] [Related]
19. Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.
Krop IE; Mittempergher L; Paulson JN; Andre F; Bonnefoi H; Loi S; Loibl S; Gelber RD; Caballero C; Bhaskaran R; Dreezen C; Menicucci AR; Bernards R; van 't Veer LJ; Piccart MJ
JCO Precis Oncol; 2024 Jan; 8():e2200667. PubMed ID: 38237097
[TBL] [Abstract] [Full Text] [Related]
20. breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018.
Ghasemi-Kebria F; Fazel A; Semnani S; Etemadi A; Naeimi-Tabiei M; Hasanpour-Heidari S; Salamat F; Jafari-Delouie N; Sedaghat S; Sadeghzadeh H; Akbari M; Mehrjerdian M; Weiderpass E; Roshandel G; Bray F; Malekzadeh R
Cancer Epidemiol; 2024 Apr; 89():102525. PubMed ID: 38228040
[TBL] [Abstract] [Full Text] [Related]
[Next]
